General and administrative (G&A) expenses were $12.4 million for the first quarter of 2025, which included $5.1 million of restructuring expenses in March 2025. Non-cash stock-based compensation ...

Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L ...

GI Innovation, a South Korean biotech company, announced on May 13 that it has been selected as a semi-finalist in the XPRIZE ...

Enrollment open in investigator-sponsored trial (IST) of NKX019 in myasthenia gravis; Ntrust-1, Ntrust-2, and IST of NKX019 in systemic lupus erythematosus remain open to enrollment Ntrust-1 expanded ...

Dr Belinda Kaskow explores the benefits of investigating the early stages of immune dysregulation in MS to enhance prevention ...

Inspired by the world's great Lego Masters, Arovella is taking a brick-by-brick approach to building its unique cancer ...

The ASX recovered from an early morning dip, lifted by strong movements in tech and banking stocks to rise 0.22pc.

FATE incurs a narrower-than-expected loss in the first quarter. The company's innovative pipeline remains in focus.

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today ...

MiNK ended the quarter with a cash balance of $3.2 million. Cash used in operations for the three months ended March 31, 2025 was $1.3 million compared to $2.5 million for the same period in 2024. Net ...

The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...

In early sixteenth century Guru Nanak Dev the founder of Sikh religion observed the pathetic condition of women in the society Guru Nanak comdemned the attitude of ...